OriGene Technologies Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:OriGene Technologies Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011299
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, transfection reagent, precisionshuttling kits, cDNA clones, HuSH shRNA, plasmid purification, siRNA, miRNA, proteins antibodies, IHC products, assays and human tissues, among others. The company’s services include gene synthesis, custom shRNA, custom cloning, custom protein service, antibody service, assay development and stable cell line development. It provides research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, and protein kinase. The company offers products and services to pharmaceutical and biotechnology companies and academic research institutes. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
OriGene Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
OriGene Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
OriGene Technologies Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
Partnerships 12
OriGene Technologies Enters into Licensing Agreement with Diadexus 12
SDIX Enters Into Licensing Agreement With BD Diagnostic 13
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
DuPont Enters Into Co-Development Agreement With OligoCo 16
Asset Transactions 17
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 17
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 19
Acquisition 20
OriGene Technologies Acquires BioCheck 20
OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 21
OriGene Technologies Inc – Key Competitors 22
OriGene Technologies Inc – Key Employees 23
OriGene Technologies Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Product News 26
Apr 14, 2016: ALK UltraMAB Antibody (OTI1A4) Outperform D5F3 Antibody, Successfully Demonstrating Higher Sensitivity in NSCLC Immunohistochemistry Diagnostics 26
Other Significant Developments 27
Jan 07, 2016: OriGene Technologies Awarded Phase II SBIR Contract to Develop High-Affinity, Anti-Peptide Monoclonal Antibodies for SISCAPA Assays 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
OriGene Technologies Inc, Medical Equipment, Key Facts 2
OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
OriGene Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
OriGene Technologies Inc, Deals By Market, 2011 to YTD 2017 8
OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
OriGene Technologies Enters into Licensing Agreement with Diadexus 12
SDIX Enters Into Licensing Agreement With BD Diagnostic 13
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
DuPont Enters Into Co-Development Agreement With OligoCo 16
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 17
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 19
OriGene Technologies Acquires BioCheck 20
OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 21
OriGene Technologies Inc, Key Competitors 22
OriGene Technologies Inc, Key Employees 23
OriGene Technologies Inc, Other Locations 24
OriGene Technologies Inc, Subsidiaries 24

★海外企業調査レポート[OriGene Technologies Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Companhia Energetica de Minas Gerais SA (CMIG4):企業の財務・戦略的SWOT分析
    Companhia Energetica de Minas Gerais SA (CMIG4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Bare Escentuals Inc.:企業の戦略的SWOT分析
    Bare Escentuals Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hisamitsu Pharmaceutical Co Inc (4530):企業の製品パイプライン分析
    Summary Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain relieving products, dermatological products, and quasi drugs, among others. Hisamitsu Pharmaceutical provides its products in …
  • Probiogen AG:企業のM&A・事業提携・投資動向
    Probiogen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Probiogen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • TBEA Xinjiang Sunoasis Co Ltd:電力:M&Aディール及び事業提携情報
    Summary TBEA Xinjiang Sunoasis Co Ltd (TBEA) is a renewable energy company that manufactures and markets solar energy products. The company offers products such as photovoltaic power generation systems, monocrystalline silicon wafers, polycrystalline silicon films, inverter control system, monocryst …
  • Orliman SLU:医療機器:M&Aディール及び事業提携情報
    Summary Orliman SLU (Orliman), a subsidiary of The Riverside Company, is a medical device company that develops and manufactures orthopedic products. The company provides products such as stabilizers, immobilizers, lumbosacral back supports, abdominal bands, abdominal belt, shoulder supports, truss, …
  • Emco Ltd (EMCO):電力:M&Aディール及び事業提携情報
    Summary Emco Ltd (Emco) is a power company that manufactures and markets electrical products and solutions. The company's products include transformers, substations, energy metering systems, and transmission towers and lines. Its transformers comprise furnace transformers, distribution transformers, …
  • Lanco Infratech Ltd (LITL):企業の財務・戦略的SWOT分析
    Lanco Infratech Ltd (LITL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • BBVA Banco Frances S.A.:企業の戦略・SWOT・財務分析
    BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report Summary BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Energy Transfer LP:企業の戦略・SWOT・財務情報
    Energy Transfer LP - Strategy, SWOT and Corporate Finance Report Summary Energy Transfer LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pernod Ricard SA:企業の戦略・SWOT・財務情報
    Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report Summary Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Jakks Pacific, Inc.
    Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AltheaDx Inc-医療機器分野:企業M&A・提携分析
    Summary AltheaDx Inc (AltheaDx) is a biotechnology company that offers molecular diagnostic services. The company provides tests such as cardiovascular tests, pain tests, thrombophilia tests and psychiatric tests. It provides diagnostic development, clinical trial and discovery services. AltheaDx’ s …
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Vital Images Inc:企業の戦略的SWOT分析
    Vital Images Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • HemaCare Corp (HEMA)-医療機器分野:企業M&A・提携分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, bone marrow and cord blood. It spans its expertise in isolations, custom cell collections and testing of pr …
  • BioCorRx Inc (BICX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioCorRx Inc (BioCorRx), formerly Fresh Start Private Management Inc, is a healthcare solution provider. The company provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers. It distributes and licenses BioCorRx recovery program, a medication …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Coresa Sa
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆